awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q38068519-73381E5D-435A-4385-8F54-341A6E012F40
Q38068519-73381E5D-435A-4385-8F54-341A6E012F40
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38068519-73381E5D-435A-4385-8F54-341A6E012F40
Adverse events associated with mTOR inhibitors.
P2860
Q38068519-73381E5D-435A-4385-8F54-341A6E012F40
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38068519-73381E5D-435A-4385-8F54-341A6E012F40
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
5ac52145a8b4488dda00d6b745d673723d3be025
P2860
Everolimus-based, calcineurin-inhibitor-free regimen in recipients of de-novo kidney transplants: an open-label, randomised, controlled trial.